Transdermal patches are adhesive patches that are medicated. They help deliver a preset dose of medication inside the body by using the transdermal technology and diffusion technique. The medication later gets into the blood stream over a period of time. These transdermal patches are used for various diseases including migraines, diabetes, Alzheimer’s, cardiac and hormonal disorders among others.
The Transdermal Patch market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.

Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.

In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Transdermal Patch industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.

The Transdermal Patch market can be split based on product types, major applications, and important countries as follows:

Key players in the global Transdermal Patch market covered in Chapter 12:
Rfl Pharmaceutical
Johnson & Johnson
Teikoku Pharma
Actavis
Mylan
Hisamitsu Pharmaceutical
Mundipharma
Changzhou Siyao
Henan Lingrui Pharmaceutical
Novartis

In Chapter 4 and 14.1, on the basis of types, the Transdermal Patch market from 2015 to 2025 is primarily split into:
Fentanyl Transdermal Patch
Nicotine Transdermal Patch
Buprenorphine Transdermal Patch
Clonidine Transdermal Patch
Oxybutynin Transdermal Patch
Others

In Chapter 5 and 14.2, on the basis of applications, the Transdermal Patch market from 2015 to 2025 covers:
Relieve severe pain
Stop smoking cigarettes
Treat an overactive bladder
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others

Years considered for this report:

Historical Years:

2015-2019

Base Year:

2019

Estimated Year:

2020

Forecast Period:

2020-2025